Losartan Urination: Why It Happens and What to Watch For

Losartan can make you urinate more frequently or in larger volumes because it changes how your kidneys handle sodium and water. It does this by blocking angiotensin II, a hormone that normally tells your body to hold onto salt and fluid. The effect is real but typically milder than what you would experience with an actual diuretic, which is why it catches some people off guard. The urinary changes go deeper than just volume, though, touching on everything from uric acid levels to protein in your urine and even bladder function.

How Losartan Changes What Your Kidneys Do With Salt and Water

Your kidneys constantly fine-tune how much sodium and water they keep versus how much they let go. A key player in that regulation is the renin-angiotensin-aldosterone system, or RAAS. When angiotensin II is active, it tells the kidneys to reabsorb more sodium from the fluid being filtered. Water follows sodium, so you retain more fluid overall. Losartan blocks the receptor that angiotensin II binds to, and the downstream result is that your kidneys let more sodium pass into the urine. More sodium in the urine pulls more water along with it, and you end up producing a larger volume of urine.

Research in animal models of heart failure has helped clarify exactly where in the kidney this happens. In rats with mild congestive heart failure, losartan treatment normalized the expression of a sodium transporter called NKCC2 in a specific part of the kidney tubule and also reduced expression of a water channel called aquaporin-2 in the collecting ducts. The practical result was that daily sodium excretion returned to normal and the kidneys stopped holding onto excess water.¹ In plain terms, losartan dials back two separate mechanisms the kidneys use to hoard salt and water, one in the loop of the tubule and one deeper in the collecting duct.

For most people starting losartan for high blood pressure, this translates to a modest increase in urine output during the first days or weeks. Your body adjusts over time as blood pressure settles into a lower range and the kidneys recalibrate. If you were retaining a lot of excess fluid before starting the medication, the early increase in urination can be more noticeable.

The Aldosterone Piece

Angiotensin II does not just act on the kidneys directly. It also stimulates the adrenal glands to release aldosterone, a hormone whose main job is telling the kidneys to reclaim sodium and excrete potassium. By blocking angiotensin II, losartan lowers aldosterone levels as well. In a human study conducted under low-salt conditions, losartan cut baseline aldosterone roughly in half and completely blocked the aldosterone surge that normally occurs when angiotensin II is infused.²

Lower aldosterone means less sodium reabsorption and, consequently, more sodium and water leaving the body through urine. It also means less potassium being dumped into the urine, which is why losartan can raise potassium levels. This is an important distinction from traditional diuretics like hydrochlorothiazide, which tend to waste potassium. If you are on losartan and notice increased urination, the trade-off is that you are less likely to become potassium-depleted compared to someone taking a diuretic, but you do need to watch for potassium creeping too high, especially if you have kidney disease or take potassium supplements.

Losartan Alone Versus the Combination With a Diuretic

Many people prescribed “losartan” are actually taking a combination pill that includes hydrochlorothiazide (HCTZ), a thiazide diuretic. This matters a lot for urination. HCTZ is a true diuretic designed specifically to increase urine output, and it works through a different mechanism than losartan. The combination produces significantly greater blood pressure reduction than losartan alone. In a trial comparing the two approaches in patients with mild to moderate hypertension, the combination lowered blood pressure roughly twice as much as losartan monotherapy at both four and eight weeks.³

If you are experiencing substantial increases in urination after starting “losartan,” check your pill bottle. If it says losartan-HCTZ (common doses include 50/12.5 mg or 100/25 mg), the diuretic component is likely doing most of the heavy lifting when it comes to extra trips to the bathroom. Losartan on its own produces a milder effect on urine volume. The distinction matters because the solutions differ: timing your dose to the morning, adjusting fluid intake around the medication, or asking your prescriber about separating the two drugs are all options when the diuretic effect is bothersome.

Uric Acid and Changes in Your Urine You Might Not Notice

One of losartan’s quirks, unique among blood pressure medications in its class, is that it lowers uric acid levels in the blood by increasing uric acid excretion through the kidneys. It does this by blocking a transporter called URAT1 that normally reclaims uric acid from the urine and sends it back into the bloodstream. Research in hypertensive patients confirmed that losartan inhibits URAT1, which is why blood uric acid levels drop during treatment.⁴

You will not feel this happening. There is no change in how often you urinate or what urination feels like. But it is a meaningful urinary change because more uric acid is leaving your body through your urine than before. For people who also have gout or elevated uric acid, this is actually a bonus. Other drugs in the same class, like valsartan or irbesartan, do not share this property, which is one reason a prescriber might specifically choose losartan for someone with both high blood pressure and hyperuricemia.

Not everyone responds equally. Genetic variation in the URAT1 transporter influences how much uric acid losartan actually pushes into the urine. Specific polymorphisms in the URAT1 gene have been shown to affect the uricosuric response to losartan in hypertensive patients with high uric acid.⁵ In practical terms, some people get a robust drop in uric acid from losartan while others see little change, and genetics is part of the explanation.

Protein in Your Urine and What It Means

If you have diabetes or kidney disease, your doctor may be monitoring protein levels in your urine while you take losartan. Protein leaking into urine (proteinuria) is a sign that the kidney’s filtering units are damaged, and losartan is one of the frontline treatments for slowing that damage. The landmark RENAAL trial in patients with type 2 diabetes and kidney disease found that losartan reduced proteinuria by about 35% compared to placebo.⁶

This effect kicks in fast. A study tracking the timeline of losartan’s antiproteinuric action in diabetic kidney disease found that the albumin-to-creatinine ratio dropped by about 29% within the first seven days and stayed at that level through the 28-day study period, with no change in blood creatinine levels during that time.⁷ So if your urine protein test improves quickly after starting losartan, that is the drug doing what it is supposed to do, not a fluke.

This is a different kind of urinary change from the increased volume discussed earlier. You are not urinating more because of reduced proteinuria. Instead, what is in your urine is changing compositionally. Less protein in the urine is a good sign, and it is one of the primary reasons losartan is prescribed for kidney protection in the first place.

When Kidney Numbers Dip After Starting Losartan

Something that alarms both patients and occasionally their doctors is a drop in estimated glomerular filtration rate (eGFR) shortly after starting losartan. The eGFR is a blood-test-derived estimate of how well your kidneys are filtering. A dip of 10 to 20 percent in the first few weeks is not unusual with drugs that block the RAAS, and counterintuitively, it can be a sign the drug is working.

Losartan relaxes the small blood vessel leaving the kidney’s filtering unit, which lowers the pressure inside that unit. Lower pressure means less mechanical strain on the filter, which protects it long-term, but it also means a temporary reduction in the rate of filtration. Analysis of data from losartan-treated patients found that an acute fall in eGFR during early treatment actually predicted a slower decline in kidney function over the long term. The researchers framed this as encouragement to continue treatment, as long as other causes of falling eGFR (like renal artery stenosis, reduced blood volume, or dangerously high potassium) can be ruled out.⁸

What you should watch for is a large, persistent, or worsening drop in eGFR rather than a small, stable one. Your prescriber will typically recheck kidney function and potassium levels a week or two after starting losartan or increasing the dose. If the dip is modest and stabilizes, treatment usually continues. If the drop is steep, it may signal an underlying problem like narrowing of the arteries that supply the kidneys.

Bladder and Prostate Effects

Increased urination frequency is not always about how much urine the kidneys produce. Sometimes it is about the bladder itself or, in men, the prostate. There is emerging evidence that losartan may influence both.

In rats with hypertension-related prostatic enlargement, losartan treatment significantly reduced prostate size and glandular tissue content, improved blood flow to the prostate, and lowered markers of inflammation, independent of its blood-pressure-lowering effects.⁹ A review of antifibrotic therapies for lower urinary tract symptoms noted that losartan also increased programmed cell death in prostate tissue and that this effect appeared to work through a pathway involving TGF-β1, a growth factor linked to tissue remodeling.¹⁰ If these findings translate to humans, losartan might eventually offer a dual benefit for men with both high blood pressure and an enlarged prostate, reducing urinary symptoms rather than causing them.

On the bladder side, research in hypertensive rats with bladder dysfunction found that low-dose losartan decreased urine output, post-voiding residual volume, and bladder capacity, while higher doses also reduced bladder wall thickness and kidney damage.¹¹ These are animal studies, and the leap to clinical recommendations is a long one. But they suggest losartan’s effects on the urinary tract go beyond simply making the kidneys produce more urine. The drug may influence how the bladder stores and empties urine in ways researchers are only beginning to map.

Sex Differences in How Losartan Affects Kidney and Heart Outcomes

Whether losartan’s kidney and cardiovascular benefits differ between men and women is a question that has received surprisingly little attention until recently. A post hoc analysis of two major trials involving people with type 2 diabetes and diabetic kidney disease found that the kidney-protective effect of angiotensin receptor blockers was similar between men and women. However, the cardiovascular benefit told a different story: the drug lowered cardiovascular risk in men but not in women, with a statistically meaningful interaction between sex and treatment effect for heart outcomes.¹²

This does not directly change how losartan affects your urination, but it is relevant context for understanding why your doctor chose this particular medication and what you should be monitoring. If you are a woman with diabetic kidney disease taking losartan primarily for heart protection, this finding raises questions worth discussing with your prescriber. The kidney benefits appear similar regardless of sex, but the cardiovascular picture is less clear-cut, and your overall monitoring plan may reflect that.

Practical Things to Watch For

Most urinary changes on losartan are benign and settle within a few weeks. But some warrant attention:

Dark or scant urine: If your urine output drops significantly or becomes much darker, you may be dehydrated. Losartan plus hot weather, illness, or inadequate fluid intake can push you toward volume depletion faster than you expect.
Foamy urine: Persistent foam can indicate protein in the urine. If you are on losartan for kidney protection and notice new foaming, mention it at your next visit. It could mean protein levels are not adequately controlled.
High potassium symptoms: Because losartan reduces aldosterone and potassium excretion, potassium can build up. Muscle weakness, irregular heartbeat, or tingling are warning signs. This risk is higher if you have reduced kidney function or use potassium-sparing supplements.
Dizziness on standing: Increased sodium and water loss can lower blood pressure enough to cause lightheadedness when you stand up, especially early in treatment. Rising slowly and staying well hydrated helps.

Timing your losartan dose in the morning can reduce nighttime trips to the bathroom if that becomes an issue. If you are taking the losartan-HCTZ combination and finding the diuretic effect disruptive, ask your prescriber whether splitting to losartan alone with a separately timed diuretic is an option. Some people tolerate the components better when they can control the timing independently.

When Increased Urination Is Not From Losartan at All

It is easy to blame a new medication for any change you notice, but increased urination has a long list of potential causes that happen to coincide with the age range of people typically starting blood pressure treatment. Undiagnosed or worsening diabetes is among the most common, and high blood sugar drives frequent urination through an entirely different mechanism: glucose spills into the urine and pulls water with it. Urinary tract infections, an overactive bladder, and in men, benign prostatic enlargement can all increase frequency independently of any medication.

A useful way to sort this out is to pay attention to when the change started relative to when you began or changed your dose of losartan. If increased urination appeared within the first few days and then stabilized, the medication is the likely cause. If it developed gradually weeks or months later, or if it comes with burning, urgency, or difficulty starting the stream, something else may be going on. Mentioning the timing to your doctor helps narrow the possibilities quickly. Losartan does affect urination, but not every urinary symptom that shows up while you are taking it belongs to the drug.